Skip to content
Monday, November 9, 2026
Smart Lounge

Patients Stopping Weight-Loss Medications Put On Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

Illustration of pharmaceutical syringe and scale
Obesity treatment often requires long-term strategies.

Fresh analysis reveals that individuals who discontinue popular weight-loss injections like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who halt traditional diet and exercise programs.

Research printed in a leading health publication demonstrates that while overweight people frequently drop a large proportion of their total mass while undergoing treatment, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.

"Users buying such treatments must be aware of the risk of fast weight regain when the therapy is stopped," stated expert Dr. Susan Jebb.

That rate of regain means a return to original weight in about one and a half years.

Weighing Treatments

The research, which looked at dozens of studies involving over 9,000 of participants, contrasted the effects of these new drugs with conventional dieting.

Researchers emphasize that people who lose weight through lifestyle changes alone typically have a more gradual creep back—around 100 grams monthly—once they finish.

Understanding the Rapid Regain

Doctors propose the mode of action of the injections accounts for the accelerated weight return.

GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which moderates appetite.

"Long-term administration of GLP-1 concentrations far above than normal could lead to the body to produce less of its own natural hormone, and may also lessen sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.

"Stopping of this medication results in hunger is unsuppressed, making overeating far more likely."

A Lifelong Condition?

Health authorities suggest the injections for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.

Many experts argue that, considering the significant potential of relapse, the therapy is often ongoing.

This perspective is echoed by pharmaceutical companies, who say that the findings "emphasize the long-term character of obesity," akin to managing diseases like high blood pressure.

User Accounts

Individuals who have discontinued the medication explain a sudden return of appetite.

"It felt as if a switch that goes on and you're instantly starving," said a patient.

The struggle is worsened if patients have not established lasting dietary or behavioural changes during therapy.

Widespread Interest

Figures show that millions of people in the UK have used these injections in the past year, with interest being substantial.

  • Adoption is greater among women compared to men.
  • The middle-aged age group shows the greatest usage rates.
  • A large proportion obtain the drugs through private prescriptions rather than public health services.

In conclusion, experts stress that while these medications are powerful tools for shedding pounds, they are not a permanent cure and long-term success hinges on combined behavioural changes.

JA
By

Johnny Adkins

A tech enthusiast and smart home consultant with over a decade of experience in home automation systems and IoT devices.

Smart Lounge

Type to search articles.